Source:http://linkedlifedata.com/resource/pubmed/id/15047102
Switch to
Predicate | Object |
---|---|
rdf:type | |
pubmed:dateCreated |
2004-3-29
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0076-6879
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
382
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
174-93
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15047102-Alkylating Agents,
pubmed-meshheading:15047102-Animals,
pubmed-meshheading:15047102-Antineoplastic Agents,
pubmed-meshheading:15047102-Aziridines,
pubmed-meshheading:15047102-Benzoquinones,
pubmed-meshheading:15047102-Clinical Trials as Topic,
pubmed-meshheading:15047102-Humans
|
pubmed:year |
2004
|
pubmed:articleTitle |
Diaziridinylbenzoquinones.
|
pubmed:affiliation |
Division of Pediatric Oncology, Policlinico Gemelli, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Review
|